|

AG chemotherapy Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Pipeline

Phase 3: 1

Top Sponsors

  • Zhejiang Cancer Hospital1

Indications

  • Non-Resectable Pancreas Carcinoma1
  • Cancer1

Other1 trial

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.